Liver resection improves the survival of patients with multiple hepatocellular carcinomas

Annals of Surgical Oncology

Volumn 16, Issue 4, 2009, Pages 848-855

  Ho, Ming Chih ^a   Huang, Guan Tarn ^a   Tsang, Yuk Ming ^a   Lee, Po Huang ^a   Chen, Ding Shinn ^a   Sheu, Jin Chuan ^a   Chen, Chien Hung ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 62149113300     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0282-7     Document Type: Article

References (24)

1. AS Befeler AM Di Bisceglie 2002 Hepatocellular carcinoma: diagnosis and treatment Gastroenterology 122 1609 1619
2. DM Parkin F Bray J Ferlay P Pisani 2001 Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 153 156
3. V Mazzaferro E Regalia R Doci S Andreola A Pulvirenti F Bozzetti 1996 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693 699
4. FY Yao L Ferrell NM Bass JJ Watson P Bacchetti A Venook 2001 Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 1394 1403
5. ST Fan CM Lo CL Liu CM Lam WK Yuen C Yeung 1999 Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths Ann Surg 229 322 330
6. H Imamura Y Seyama N Kokudo A Maema Y Sugawara K Sano 2003 One thousand fifty-six hepatectomies without mortality in 8 years Arch Surg 138 1198 1206 discussion 206
7. J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 1208 1236
8. M Makuuchi N Kokudo S Arii S Futagawa S Kaneko S Kawasaki 2008 Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan Hepatol Res 38 37 51
9. SG Lee S Hwang 2005 How I do it: assessment of hepatic functional reserve for indication of hepatic resection J Hepatobiliary Pancreat Surg 12 38 43
10. CC Wu SB Cheng WM Ho JT Chen TJ Liu FK P'Eng 2005 Liver resection for hepatocellular carcinoma in patients with cirrhosis Br J Surg 92 348 355
11. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. AJCC cancer staging manual. 6th ed. Chicago: Springer; 2002.
12. The Cancer of the Liver Italian Program (CLIP) investigators 1998 A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients Hepatology 28 751 755
13. JM Llovet C Bru J Bruix 1999 Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 329 338
14. M Makuuchi K Sano 2004 The surgical approach to HCC: our progress and results in Japan Liver Transpl 10 S46 S52
15. T Ishizawa K Hasegawa T Aoki M Takahashi Y Inoue K Sano 2008 Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma Gastroenterology 134 1908 1916
16. G Torzilli M Donadon M Marconi A Palmisano D Del Fabbro A Spinelli 2008 Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona clinic liver cancer classification: results of a prospective analysis Arch Surg 143 1082 1090
17. JH Wang CS Changchien TH Hu CM Lee KM Kee CY Lin 2008 The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma-Survival analysis of 3892 patients Eur J Cancer 44 1000 1006
18. JM Llovet J Bruix 2003 Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival Hepatology 37 429 442
19. CM Lo H Ngan WK Tso CL Liu CM Lam 2002 Poon, RT, et al Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 1164 1171
20. JM Llovet MI Real X Montaña R Planas S Coll J Aponte 2002 Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734 1739
21. YH Huang CH Chen TT Chang SC Chen JH Chiang HS Lee 2005 The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stage Aliment Pharmacol Ther 21 687 694
22. JM Llovet S Ricci V Mazzaferro P Hilgard E Gane JF Blanc 2008 Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378 390
23. JM Llovet J Bruix 2008 Molecular targeted therapies in hepatocellular carcinoma Hepatology 48 1312 1327
24. CY Lin KM Kee JH Wang CM Lee CL Chen CS Changchien 2009 Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups Liver Int 29 74 81